Crescendo Biologics
Home
About Us
Overview
Investors
Strategic Collaborations
Our Science
Humabody
®
V
H
Platform
News & Events
Press Releases
Publications
Contact Us
LinkedIn
Twitter
Contact Us
Home
About Us
Overview
Investors
Strategic Collaborations
Our Science
Humabody
®
V
H
Platform
News & Events
Press Releases
Publications
Home
About Us
Overview
Investors
Strategic Collaborations
Our Science
Humabody
®
V
H
Platform
News & Events
Press Releases
Publications
Contact Us
LinkedIn
Twitter
Crescendo Biologics’ second oncology-targeted Humabody® licensed by Takeda
View PDF
Post navigation
Next Post
Next
Crescendo Biologics strengthens leadership team with appointment of ex-GSK Stewart Kay, as Chief Business Officer
We use cookies to give you a better experience on our website. To find out more, and to manage your preferences, please consult our
Privacy and Cookie Notice
.
I Accept